LGALS9 and hepatocellular carcinoma: Enhanced expression of Gal-9 following HBV infection can interact with its ligand, T cell immunoglobulin and mucin-domain containing-3 (TIM-3), mediate T-cell senescence inducing tumor immune escape in HBV-associated HCC (Li et al., 2012; Lai et al., 2017).